Stephanie Li

Feb 19, 2024 | asia.nikkei.com | Stephanie Li |Dealstreet Asia

HONG KONG -- Asia's family offices (FOs) are looking to ramp up allocation toward digital assets as liquid strategies garner significant attention among affluent individuals and families in the region, according to wealth managers. "What we are observing is a trend where family offices already invested in the industry are planning to increase their allocations," Zann Kwan, managing partner and chief investment officer for Revo Digital Family Office, told DealStreetAsia in an email interview.

Jan 16, 2024 | asia.nikkei.com | Stephanie Li |Dealstreet Asia

HONG KONG -- Asian digital asset management firm HashKey Group has sealed a $100 million Series A financing round to join the unicorn club -- startup companies valued at $1 billion and above -- at a pre-money valuation of $1.2 billion. Hong Kong-headquartered HashKey Group roped in prominent institutional investors, leading Web3 institutions and strategic partners for the Series A round, a company release stated without divulging the investors' details.

Sep 1, 2023 | asia.nikkei.com | Stephanie Li |Dealstreet Asia

HONG KONG -- Chinese smart electric vehicle company Avatr Technology, backed by state-run automaker Chongqing Changan Automobile and EV battery giant Contemporary Amperex Technology (CATL), said it has secured 3 billion yuan ($411.5 million) in a Series B funding round. The news on Thursday comes after Hozon New Energy Automobile sealed a 7 billion yuan crossover financing round on Wednesday, marking another major transaction in the Chinese EV sector in just one week.

Jun 19, 2023 | caixinglobal.com | Stephanie Li

00:00/00:00 您的浏览器不支持 audio 标签。 Listen to this article 1x (DealStreatAsia) — Beijing ESWIN Computer Technology Co. Ltd., a Chinese provider of artificial intelligence of things (AIoT) chips and services, has secured 3 billion yuan ($421 million) in a Series D financing round.

Jun 14, 2023 | asia.nikkei.com | Stephanie Li |Dealstreet Asia

HONG KONG -- The year 2023 will be a tough one for pre-revenue biotechnology companies to go public in Hong Kong, according to Serena Shao, founder and managing partner of health care-focused investment firm Ascendum Capital. "I think the market is still tough, especially for IPOs via Chapter 18A," Shao told DealStreetAsia in an interview.